H60 Activators comprise a selection of chemical compounds that interact with intricate cellular signaling networks, thereby amplifying the activity of H60. Forskolin and A23187 are such activators that employ different elements like cAMP and calcium ions, respectively, to potentiate the signaling pathways that H60 is part of. Forskolin raises cAMP levels, activating PKA, which in turn can phosphorylate substrates in signaling pathways involving H60, leading to its enhanced activity. A23187, on the other hand, increases intracellular calcium concentrations, triggering calcium-dependent pathways that can augment the activity of H60. Similarly, Genistein and EGCG reduce competition in tyrosine kinase and other kinase-related signaling by inhibiting specific tyrosine kinases and other kinases, respectively, which paves the way for H60 functional enhancement through less hindered signaling routes.
The impact on H60 activity is further influenced by the modulation of lipid signaling with compounds like Sphingosine-1-phosphate, and the alteration of protein kinase activities by PMA, LY294002, Wortmannin, and Staurosporine. Sphingosine-1-phosphate activates signaling cascades that ultimately enhance H60's role, whereas PMA directly stimulates PKC, leading to downstream effects that bolster H60 activity. LY294002 and Wortmannin are PI3K inhibitors, which by altering the PI3K/AKT pathway, allow for the activation of alternate pathways linked to H60 activity. Moreover, SB203580 and U0126, through the inhibition of p38 MAPK and MEK1/2 respectively, indirectly foster an environment where H60 can be more active by shifting signaling dynamics in favor of pathways that involve H60. Thapsigargin's role in increasing cytosolic calcium further contributes to the enhancement of H60, considering its effect on calcium-dependent signaling mechanisms. Collectively, these activators orchestrate a conducive signaling milieu that supports the enhanced functional activity of H60, without necessitating the upregulation of its expression or direct activation.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylate cyclase, which increases intracellular cAMP levels. The elevated cAMP activates PKA, which can phosphorylate various substrates leading to enhanced activity of H60 through cAMP-dependent signaling pathways. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that allows for reduced competition in tyrosine kinase signaling pathways, which indirectly enhances the functional activity of H60 by modulating the downstream effects of these pathways. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate engages with its receptors to activate intracellular signaling cascades, including PLC, which can lead to the activation of signaling pathways that potentiate H60's function. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis by inhibiting the SERCA pump, which leads to an increase in cytosolic calcium levels, indirectly enhancing H60 activity through calcium-dependent signaling mechanisms. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is involved in the regulation of numerous signaling pathways. The activation of PKC can lead to the phosphorylation of proteins that are part of the signaling cascades influencing H60 activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG acts as a kinase inhibitor, thereby altering signaling pathways, which may lead to the upregulation of processes that increase the functional activity of H60 indirectly. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that alters the PI3K/AKT pathway, which can lead to the activation of alternative pathways that enhance the activity of H60. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits PI3K, which can upregulate alternative pathways and indirectly enhance H60's functional activity through signaling cascades not reliant on PI3K. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 selectively inhibits p38 MAPK, which may lead to the activation of compensatory pathways that can enhance the activity of H60. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as an ionophore that increases intracellular calcium levels, thereby activating calcium-dependent signaling pathways that can enhance the activity of H60. | ||||||